Methylprednisolone Acetate Injection — FDA Drug Shortage

Current — Sagent Pharmaceuticals

The FDA lists a drug shortage record for Methylprednisolone Acetate Injection (injection) from Sagent Pharmaceuticals with status Current. The shortage was first posted on Dec 15, 2021.

Shortage details

Status
Current
Company
Sagent Pharmaceuticals
Package NDC
25021-820-05
Dosage Form
Injection
Presentation
Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-05)
Initial Posting
Dec 15, 2021

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.